Package Insert: Information for the User
Navixen Plus 600 mg/12.5 mg Film-Coated Tablets
eprosartan and hydrochlorothiazide
Read this package insert carefully before starting to take this medicine because
it contains important information for you.
Package Insert Content:
Package Contents and Additional Information
Navixen Plus is used:
Navixen Plus contains two active ingredients, eprosartan and hydrochlorothiazide.
You will only take Navixen Plus if your blood pressure does not decrease sufficiently with
eprosartan alone.
Do not take Navixen Plus if:
- you are allergic to eprosartan, hydrochlorothiazide, or any of the other components of this medication (listed in section 6)
- you are allergic to a group of medications called “sulfonamides”
- you have severe liver disease
- you have severe kidney problems
- you have severe blood flow problems in your kidneys
- you have diabetes or kidney insufficiency and are being treated with a medication to lower blood pressure that contains aliskiren
- you have high levels of calcium or low levels of potassium or sodium. These levels can be measured in your blood
- you have a problem with your gallbladder or bile ducts (biliary calculi)
- you have gout or other signs of an increase in uric acid levels in your blood (hyperuricemia)
- if you are more than 3 months pregnant (also avoid taking Navixen Plus at the beginning of pregnancy – see the pregnancy section)
Do not take Navixen Plus if any of the above applies to you. If you are unsure, consult your doctor or pharmacist before taking this medication.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take Navixen Plus if:
- you have any other liver problems
- you have had a kidney transplant
- you have other kidney problems. Your doctor will examine how your kidneys are functioning before starting your treatment and at intervals during your treatment. Your doctor will also monitor your potassium, creatinine, and uric acid levels in your blood
- you have a heart problem such as coronary heart disease, heart failure, a narrowing of your blood vessels or heart valves, or a problem with your heart muscle
- you have a disease called “Systemic Lupus Erythematosus” (SLE)
- you have diabetes. Your doctor may need to change the dose of your diabetes medications
- you produce too much of a hormone called “aldosterone”
- you have a history of allergies
- you are on a low-sodium diet, taking “diuretics” (diuretics), or vomiting or have diarrhea. This is because they can cause your blood volume or sodium levels in your blood to decrease. These situations must be corrected before starting treatment with Navixen Plus
- if you are taking any of the following medications used to treat high blood pressure (hypertension):
- an angiotensin-converting enzyme inhibitor (ACE inhibitor) (e.g. enalapril, lisinopril, ramipril), particularly if you have kidney problems related to diabetes
- aliskiren
Your doctor may need to monitor your renal function, blood pressure, and electrolyte levels in your blood (e.g. potassium) at regular intervals.
See also the information under the heading “Do not take Navixen Plus”.
- you think you are pregnant (or plan to be). This medication is not recommended at the beginning of pregnancy and should not be taken if you are more than 3 months pregnant, as it may cause severe damage to the baby if found in this stage (see the pregnancy section)
- if you have had respiratory or pulmonary problems (such as inflammation or fluid in the lungs) after taking hydrochlorothiazide in the past. If you experience severe shortness of breath or difficulty breathing after taking this medication, seek medical attention immediately
- if you have had skin cancer or if you develop an unexpected skin lesion during treatment. The treatment with hydrochlorothiazide, particularly its long-term use at high doses, may increase the risk of certain types of skin cancer and lip cancer (non-melanoma skin cancer). Protect your skin from sun exposure and UV rays while taking this medication
- if you experience a decrease in vision or eye pain, which may be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or increased pressure in the eye (glaucoma) and may occur between hours and weeks after taking Navixen Plus. This may lead to permanent vision loss if not treated. If you have previously had an allergy to penicillin or sulfonamide, you may be at higher risk of developing it, and you should interrupt treatment and seek medical attention
- if you are a black patient, as this medication may be less effective in reducing blood pressure
If any of the above applies to you (or you are unsure), consult your doctor or pharmacist before taking this medication.
Treatment with hydrochlorothiazide may cause an electrolyte imbalance in your body. Your doctor should monitor your electrolyte levels in your blood regularly.
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Navixen Plus. Your doctor will decide whether to continue treatment. Do not stop taking Navixen Plus on your own.
Children and adolescents
Navixen Plus should not be administered to children and adolescents under 18 years old.
Surgery and tests
Consult your doctor or pharmacist before taking this medication if you have planned the following:
- surgery or surgery
- a doping test. The hydrochlorothiazide in this medication may give a positive result
- any other blood test.
Taking Navixen Plus with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This includes medications obtained without a prescription, including herbal remedies. This is because this medication may affect how other medications work. Also, some medications may affect how Navixen Plus works.
Particularly, consult your doctor or pharmacist if you are taking the following:
If any of the above applies to you (or you are unsure), consult your doctor or pharmacist before taking this medication.
Your doctor may need to modify your dose and/or take other precautions:
If you are taking an ACE inhibitor or aliskiren (see also the information under the headings “Do not take Navixen Plus” and “Warnings and precautions”.
The following medications may reduce the effect of Navixen Plus:
If any of the above applies to you (or you are unsure), consult your doctor or pharmacist before taking Navixen Plus.
The following medications may increase the effect of Navixen Plus:
If any of the above applies to you (or you are unsure), consult your doctor or pharmacist before taking this medication.
If you are taking any of the following medications, your doctor may need to perform blood tests:
Consult your doctor or pharmacist before taking this medication. Depending on the results of your blood tests, your doctor may decide to change your treatment with these medications or Navixen Plus.
Taking Navixen Plus with food, drinks, and alcohol
Consuming alcohol while taking this medication may reduce your blood pressure and make you feel drowsy or dizzy.
Consult your doctor before taking Navixen Plus if you are following a low-sodium diet.
Not having enough salt may cause your blood volume or sodium levels in your blood to decrease.
Pregnancy
Breastfeeding
If you are pregnant or breastfeeding, think you might be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and using machines
It is unlikely that Navixen Plus will affect your ability to drive or use machines. However, you may feel drowsy or dizzy while taking this medication. If this happens, do not drive or use tools or machines and consult your doctor.
Navixen Plus contains lactose (a type of sugar)
If your doctor has told you that you have a lactose intolerance, consult him before taking this medication.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Medication Intake
How to Take It
Adults
The usual dose is one tablet per day.
Use in Children and Adolescents
Navixen Plus should not be administered to children and adolescents under 18 years old. Safety and efficacy have not been established.
If You Take More Navixen Plus Than You Should
In case of overdose or accidental ingestion, consult the Toxicological Information Service, phone: 91.562.04.20, or consult your doctor or go to the hospital immediately.Bring the medication packaging with you. The following side effects may appear:
• Light dizziness and dizziness due to a drop in blood pressure (hypotension)
• Feeling of discomfort (nausea)
• Drowsiness
• Feeling of thirst (dehydration).
If You Forget to Take Navixen Plus
If you forget to take a dose, take it as soon as you remember.
If you forget to take a dose and the next dose is near, omit the missed dose.
Do not take a double dose to compensate for the missed doses.
If You Interrupt Treatment with Navixen Plus
Do not stop taking Navixen Plus without consulting your doctor first.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
This medicine may cause the following side effects:
Allergic reactions
If you have an allergic reaction, stop taking Navixen plus and see a doctor immediately. Symptoms may include:
Other possible side effects of Navixen plus include:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
- increased blood glucose level (hyperglycemia)
Uncommon(may affect up to 1 in 100 people)
- increased uric acid level (gout)
- increased cholesterol level
- decreased levels of potassium, sodium, and chloride
- decreased white blood cell count
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect fewer than 1 in 10,000 people)
acute respiratory distress syndrome (symptoms include severe difficulty breathing, fever, weakness, and confusion).
Frequency not known(frequency that cannot be estimated from available data):
Loss of appetite, jaundice,decreased vision or eye pain due to high pressure [possible signs of fluid accumulation in the vascular layer of the eye (choroidal hemorrhage) or acute angle-closure glaucoma],feeling uneasy, changes in blood cell count: decreased granulocytes and platelets, alterations in red blood cell formation; decreased magnesium level in the blood, increased levels of calcium and triglycerides in the blood, renal disorders, inflammation of the kidney, acute renal failure, inflammation of the blood vessel wall, formation of bubbles in the skin including dead skin cells (toxic epidermal necrolysis), skin eruption/lesions in general in sun-exposed areas due to an autoimmune disease (cutaneous lupus erythematosus), systemic lupus erythematosus, joint pain (arthralgia), severe allergic reactions (anaphylactic reactions), increased sensitivity to sunlight (photosensitivity), skin and lip cancer (non-melanoma skin cancer).Intestinal angioedema: intestinal inflammation has been reported, presenting symptoms such as abdominal pain, nausea, vomiting, and diarrhea after use of similar products.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse,even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humano https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box after CAD or EXP. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Navixen Plus
Appearance of the product and contents of the packaging
Oral coated tablets, white-yellowish in color, and capsule-shaped.
The tablets have the inscription “5147” on one of the faces.
Navixen Plus is packaged in blisters in boxes containing 28 or 56 tablets or in a clinical pack of 280 (28x10) tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible for manufacturing
Mylan Laboratories SAS
Route de Belleville Lieu dit Maillard
F- 01400 Châtillon-sur-Chalaronne, France
You can request more information about this medication by contacting the local representative of the holder of the marketing authorization:
Viatris Pharmaceuticals, S.L.
C/ General Aranaz, 86
28027 Madrid
Spain
Last review date of this leaflet:January2025
The detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) https://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.